Verastem, Inc. (VSTM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.38+0.02 (+1.47%)
At close: 4:00 PM EDT
People also watch:
STMLOMEDCCXIEPZMTTPH
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.37
Prev Close1.36
Bid1.37 x 2500
Ask1.48 x 800
Day's Range1.36 - 1.39
52wk Range1.05 - 6.81
1y Target EstN/A
Market Cap51.05M
P/E Ratio (ttm)-1.15
Beta2.77
Volume141,767
Avg Vol (3m)309,588
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press22 days ago

    Verastem reports 2Q loss

    On a per-share basis, the Needham, Massachusetts-based company said it had a loss of 23 cents. Losses, adjusted for stock option expense, were 18 cents per share. The results exceeded Wall Street expectations. ...

  • Business Wire22 days ago

    Verastem Reports Second Quarter 2016 Financial Results

    Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today reported financial results for the second quarter ended June 30, 2016, and also provided an overview of certain corporate developments.

  • Business Wire2 months ago

    Verastem to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

    Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Wednesday, July 13th at 3:30 PM Eastern Time at Le Parker Meridien New York.